The Alberta ODT Virtual Training Programincludes:

The Alberta ODT Virtual Training Program is a critical component of broader efforts to respond to the opioid crisis in Alberta by improving thecapacity of prescribers and allied health care team members involved in treating individuals with opioid use disorder (OUD).

The Alberta Opioid Dependency Treatment(ODT) Virtual Training Program

The Alberta ODT Virtual Training Program aligns with current evidence, regulations and national guidelines, and satisfies the College of Physician & Surgeons of Alberta (CPSA) requirements for initiating and maintaining opioid agonist therapy (OAT).

Royal College of Physicians and Surgeons of Canada (RCPSC) Accreditation: 10 hours MOC Section 3 (Self- Assessment Learning)College of Family Physicians of Canada (CFPC) Certification: 10 credits Mainpro+ Self-Learning

Seven (7) interactive eLearning modules

Ten (10) subject matter expert (SME)interviewsFive (5) Entrustable Professional Activity(EPA) Simulations

You can access the training program either through:1. The Office of Continuing Medical Education, Cummings School of Medicine - http://ecme.ucalgary.ca/

2. The Alberta Health Services external webpage - www.ahs.ca/PACES

SpecialPopulations

07 KNOWLEDGEDiscuss the prevalence of OUD across developmental and special populationcohorts; Describe prescribing OAT recommendations & special considerationsfor each population cohort.

SME INTERVIEWSExplain clinical interactions & strategies most supportive to the uniquerequirements of demographic and special population cohorts presenting withOUD.

Treatment Planning:PsychosocialInterventions

06 KNOWLEDGEDescribe integrated treatment; Discuss how motivation for change &comprehensive assessment inform psychosocial intervention & treatmentplacement; Explain the goals of psychosocial treatment;

SME INTERVIEWSExplain the efficacy of various psychosocial interventions in relation to opioiduse disorder

Treatment Planning: Opioid Agonist

Treatment (OAT)Therapy

05KNOWLEDGEDefine opioid agonist treatment (OAT) therapy and how aligns with thespectrum of treatment intensity; Describe 1st line vs 2nd line treatmentrecommendations; Explain how to initiate, maintain and convert whenprescribing OAT therapies.

SME INTERVIEWSExplain efficacy of medically assisted withdrawal treatment; Describe specialtyled OAT therapy (SROM & iOAT); Explain clinical requirements & nuances ofOAT monitoring.

EPA-SIMULATIONSInitiate an individual on methadone; initiate an individual on Buprenorphine /naloxone through home induction; Convert an individual frommethadone to buprenorphine/naloxone.

Reducing Harm& Recognizing

Opioid Poisoning

04 KNOWLEDGEDefine harm reduction and the philosophy & principles behind it; Describefour primary components of harm reduction; Explain the signs and symptomsof opioid intoxication and poisoning.

SME INTERVIEWSExplain harm reduction approaches as relates to opioid use disorder andcurrent initiatives underway in Alberta.

EPA-SIMULATIONSAssess for an opioid poisoning and respond with administration of Naloxone

Impact of Opioid Use

03KNOWLEDGEExplain the neurobiology of addiction; Describe Opioid Use Disorder; Discussthe impacts of opioids on mental & physical health; Explore OUD across special populations;

SME INTERVIEWSDiscuss the biopsychosocial-spiritual model of addiction; Explain the components of a comprehensive assessment for opioid dependency treatment.

EPA-SIMULATIONConduct a comprehensive assessment for opioid use disorder (OUD).

UnderstandingOpioids

02 KNOWLEDGEDescribe how opioids evolved; Explain the impact opioids have on the brainand body, and the routes of administration; Describe the various opioidsavailable;

SME INTERVIEWSExplain the endogenous/ exogenous system and interaction with opioidreceptors. Explain opioid agonist activity and affinity; Describe current trendsin opioid use.

The OpioidCrisis

01 KNOWLEDGEDescribe the national and provincial impact of the current opioid crisis; Describe current action, legislation, and prescribing guidelines that havebeen established in response to the opioid crisis.

SME INTERVIEWSExplain how Canada’s current opioid crisis came to be; Explain the impact ofthe opioid crisis on individuals, and families.

Please submit your questions and de-identified client scenarioinquiries to concurrent.disorders@ahs.ca.

Questions and case scenarios will be themed & discussed during themonthly course webinar, and the monthly ODT Virtual Health LearningSessions.

------ Module Guide ------The Alberta ODT Virtual Training Program